✦ LIBER ✦

Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without type 2 diabetes

✍ Scribed by Jun Iwamoto; Yoshihiro Sato; Mitsuyoshi Uzawa; Tsuyoshi Takeda; Hideo Matsumoto

Book ID: 116407122
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 451 KB
Volume: 93
Category: Article
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2011.03.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Three-year Experience with Alendronate T

Three-year Experience with Alendronate Treatment in Postmenopausal Osteoporotic Japanese Women with or without Renal Dysfunction

✍ Dr Jun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, Tsuyoshi Takeda… 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 181 KB

Effects of one year daily teriparatide t

Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate

✍ Sonja Gamsjaeger; Birgit Buchinger; Ruth Zoehrer; Roger Phipps; Klaus Klaushofer 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Effects of one year daily teriparatide t

Effects of one year daily teriparatide treatment on iliac bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women treated prior with alendronate or risedronate

✍ B.M. Misof; E.P. Paschalis; R. Zoehrer; S. Blouin; N. Fratzl-Zelman; R. Phipps; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Effects of 1 year of daily teriparatide

Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate

✍ Barbara M Misof; Eleftherios P Paschalis; Stéphane Blouin; Nadja Fratzl-Zelman; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 163 KB 👁 1 views

## Abstract Anabolic treatment with teriparatide of postmenopausal osteoporotic patients previously treated with bisphosphonates is a new therapeutic approach. However, its effects on the bone mineralization density distribution (BMDD) are unknown. We studied paired transiliac bone biopsy samples t

Changes in trabecular bone microarchitec

Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: a two year longitudinal study

✍ Janet M Pritchard, Lora M Giangregorio… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 472 KB

Three-month treatment with pioglitazone

Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes

✍ Hideaki Nakatsuji; Ken Kishida; Tohru Funahashi; Iichiro Shimomura 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 148 KB